je.st
news
Orexigen's Contrave Sales Recover - Investors Should Look To Europe
2015-02-19 12:27:30| Biotech - Topix.net
Contrave, the anti-obesity pill from Orexigen saw sales increase by 10% this past week. Contrave sold just above 8,400 scripts for its best week to date.
Tags: to
sales
europe
investors
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||